Literature DB >> 21693453

Giant ganglioneuroma of the posterior mediastinum.

Javed Hayat1, Riaz Ahmed, Shereen Alizai, Muhammad Umer Awan.   

Abstract

We report the case of a 45-year-old female referred to us with progressive shortness of breath and a huge left mediastinal mass. Computed tomography of the chest revealed a mass occupying the posterior mediastinum and extending from the apex caudally to the left hemidiaphragm. Further magnetic resonance imaging demonstrated tumor extension to the left interverteberal foramina of T5-T6 and T6-T7. Excision of the mass was performed through a left posterolateral thoracotomy. Histology confirmed a mediastinal ganglioneuroma. This is an unusual tumor with more than one extension in the spine. Ganglioneuromas are rare tumors of the peripheral nervous system. Most of these tumors are, however, retroperitoneal and are more common in children and young adults. Ganglioneuromas arise from neural crest cells. These tumors are mostly asymptomatic, but some may present with hypertension and flushing. Massive tumors can present with pressure symptoms.

Entities:  

Mesh:

Year:  2011        PMID: 21693453     DOI: 10.1510/icvts.2011.267393

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  4 in total

Review 1.  Incidental ganglioneuromas: a presentation of 14 surgical cases and literature review.

Authors:  C Spinelli; L Rossi; A Barbetta; C Ugolini; S Strambi
Journal:  J Endocrinol Invest       Date:  2014-12-13       Impact factor: 4.256

2.  Mediastinal ganglioneuroma with osseous invasion simulating malignant transformation of osteochondroma on CT imaging.

Authors:  Cameron L Brock; Apoorva Sharma; Fabio A Villada; Johanna Schubert
Journal:  Radiol Case Rep       Date:  2020-10-28

3.  Surgical treatment of giant mediastinal tumors.

Authors:  Yu Fang; Zhiming Qin
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2021-01-13       Impact factor: 0.332

4.  Trends, Symptoms, and Outcomes of Resectable Giant Mediastinal Tumors.

Authors:  Xiaoshun Shi; Xiguang Liu; Xiaoying Dong; Hua Wu; Kaican Cai
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.